Results for "Mitochondrial Myopathies"
Conditions Encyclopedia Entry 1777409054
** This encyclopedia entry provides an in-depth look at **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial Myopathies (MMs) are a group of rare, inherited disorders that affect the mitochondria, the energy-producing structures within cells. MMs are characterized by the accumulation of mutations in the mitochondrial DNA (mtDNA), leading to impaired energy production and cellular dysfunction. This results in a range of symptoms, including muscle weakness, fatigue, and other systemic problems. MMs are often inherited in an autosomal dominant or maternal pattern, meaning that a single copy of the mutated gene is sufficient to cause the condition, and it is usually passed down from the mother. Mitochondrial Myopathies are a diverse group of disorders, with over 150 different mutations identified in the mtDNA. The most common forms of MMs include **Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like episodes (MELAS)**, **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**, and **Kearns-Sayre Syndrome (KSS)**. Each of these conditions has distinct clinical features and age of onset, but they all share a common underlying defect in mitochondrial function. ## History/Background The study of Mitochondrial Myopathies dates back to the 1960s, when the first cases were described in the medical literature. However, it wasn't until the 1980s that the genetic basis of these disorders was identified. The discovery of the first mitochondrial DNA mutation in 1988 marked a significant turning point in the field, and since then, numerous studies have shed light on the molecular mechanisms underlying MMs. Today, MMs are recognized as a distinct group of disorders, with a growing body of research focused on understanding their pathophysiology and developing effective treatments. ## Key Information * **Prevalence:** MMs are rare, affecting approximately 1 in 5,000 to 1 in 10,000 people worldwide. * **Causes:** MMs are caused by mutations in the mitochondrial DNA, which are inherited from the mother. * **Symptoms:** Symptoms of MMs can vary widely, but often include muscle weakness, fatigue, seizures, and other systemic problems. * **Diagnostic tests:** Diagnosis is typically made using a combination of clinical evaluation, genetic testing, and muscle biopsy. * **Treatment:** There is no cure for MMs, but treatment options include medications to manage symptoms, physical therapy, and lifestyle modifications. ## Significance Mitochondrial Myopathies are significant because they highlight the importance of mitochondrial function in maintaining cellular health. MMs also underscore the complex interplay between genetic and environmental factors in disease development. Furthermore, the study of MMs has led to a greater understanding of the role of mitochondria in various diseases, including neurodegenerative disorders and cancer. INFOBOX: - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** 1960s (first cases described) - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting mitochondrial function TAGS: Mitochondrial Myopathies, Mitochondrial DNA, Genetic disorder, Muscle weakness, Fatigue, Seizures, Rare disease, Neurodegenerative disorder, Cancer.
Health & MedicineConditions Encyclopedia Entry 1779228126
Mitochondrial myopathies are a group of rare genetic disorders characterized by the impaired functioning of the mitochondria, leading to muscle weakness and other systemic symptoms. ## Overview Mitochondrial myopathies are a diverse group of disorders caused by mutations in the mitochondrial DNA or nuclear DNA that affect the functioning of the mitochondria. Mitochondria are the energy-producing structures within cells, and their dysfunction leads to a range of symptoms, including muscle weakness, fatigue, and other systemic problems. These disorders are often inherited in an autosomal dominant or maternal pattern, meaning they can be passed down from parent to child or inherited solely from the mother. Mitochondrial myopathies can affect individuals of any age, from childhood to adulthood, and can have a significant impact on quality of life. Mitochondrial myopathies are often classified into several subtypes, including Kearns-Sayre syndrome, MELAS syndrome, and myoclonic epilepsy with ragged-red fibers (MERRF). Each subtype has distinct clinical features and genetic mutations. For example, Kearns-Sayre syndrome is characterized by progressive external ophthalmoplegia, cardiac conduction abnormalities, and endocrine dysfunction, while MELAS syndrome is associated with encephalopathy, lactic acidosis, and stroke-like episodes. ## History/Background The first reported cases of mitochondrial myopathies date back to the 1960s, when researchers began to identify the role of mitochondria in energy production and the impact of their dysfunction on cellular function. The discovery of the mitochondrial DNA in the 1960s and the development of techniques for analyzing mitochondrial DNA in the 1980s led to a greater understanding of the genetic basis of these disorders. Since then, numerous studies have identified the genetic mutations responsible for various subtypes of mitochondrial myopathies. ## Key Information Mitochondrial myopathies are caused by mutations in the mitochondrial DNA or nuclear DNA that affect the functioning of the mitochondria. The most common genetic mutations associated with these disorders include point mutations, deletions, and duplications of mitochondrial DNA. These mutations can lead to impaired energy production, oxidative stress, and cellular damage. Symptoms of mitochondrial myopathies can vary widely depending on the subtype and severity of the disorder. Common symptoms include: * Muscle weakness and fatigue * Exercise intolerance * Muscle pain and cramping * Cardiac conduction abnormalities * Endocrine dysfunction * Neurological symptoms, such as seizures and cognitive impairment Diagnosis of mitochondrial myopathies typically involves a combination of clinical evaluation, genetic testing, and muscle biopsy. Genetic testing can identify the specific genetic mutation responsible for the disorder, while muscle biopsy can provide information on the extent of mitochondrial dysfunction. ## Significance Mitochondrial myopathies are a significant public health concern due to their rarity and impact on quality of life. These disorders can have a profound effect on individuals and families, affecting not only physical health but also emotional and psychological well-being. While there is currently no cure for mitochondrial myopathies, various treatments are available to manage symptoms and slow disease progression. Research into mitochondrial myopathies has led to a greater understanding of the role of mitochondria in energy production and the impact of their dysfunction on cellular function. This knowledge has far-reaching implications for the development of treatments for a range of diseases, including neurodegenerative disorders and cancer. INFOBOX: - Name: Mitochondrial Myopathies - Type: Rare Genetic Disorders - Date: 1960s (first reported cases) - Location: Global (affects individuals worldwide) - Known For: Impaired functioning of mitochondria leading to muscle weakness and other systemic symptoms TAGS: Mitochondrial Myopathies, Kearns-Sayre Syndrome, MELAS Syndrome, MERRF, Rare Genetic Disorders, Mitochondrial DNA, Nuclear DNA, Muscle Weakness, Fatigue, Exercise Intolerance.
Health & MedicineConditions Encyclopedia Entry 1776004864
Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells, leading to muscle weakness, fatigue, and other systemic symptoms.
Health & MedicineConditions Encyclopedia Entry 1776243964
Mitochondrial myopathies are a group of rare genetic disorders characterized by the accumulation of abnormal **mitochondrial DNA** mutations, leading to impaired energy production in muscle cells and various systemic symptoms.
Health & MedicineConditions Encyclopedia Entry 1777609755
** This entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial Myopathies (MM) are a group of rare genetic disorders caused by mutations in the mitochondrial DNA. These conditions affect the mitochondria, the energy-producing structures within cells, leading to muscle weakness, fatigue, and other systemic symptoms. Mitochondrial Myopathies are typically inherited in a maternal lineage, as only egg cells contribute mitochondria to the developing embryo. This means that the condition is passed down from mother to child. There are over 150 known mitochondrial myopathies, each caused by a specific mutation in the mitochondrial DNA. The most common forms of MM include Kearns-Sayre Syndrome (KSS), Myoclonic Epilepsy with Ragged-Red Fibers (MERRF), and Chronic Progressive External Ophthalmoplegia (CPEO). Each of these conditions has distinct symptoms and progression rates, but they all share a common thread: the progressive decline of mitochondrial function. ## History/Background The first reported case of a mitochondrial myopathy was in 1957, when a British neurologist named John N. Walton described a patient with a rare condition characterized by progressive external ophthalmoplegia (PEO) and other systemic symptoms. However, it wasn't until the 1980s that the genetic basis of these conditions was understood. The discovery of the mitochondrial DNA and its role in energy production paved the way for the identification of the genetic mutations responsible for MM. ## Key Information Mitochondrial Myopathies are characterized by a range of symptoms, including: * Muscle weakness and wasting * Fatigue and exercise intolerance * Eye movement disorders (e.g., PEO) * Epilepsy and seizures * Hearing loss and vision impairment * Cardiac conduction abnormalities * Cognitive decline and dementia The progression and severity of MM vary widely depending on the specific mutation and individual factors. Some people may experience a slow and gradual decline, while others may experience a more rapid progression. ## Significance Mitochondrial Myopathies are a significant public health concern due to their rarity and the lack of effective treatments. While there is no cure for MM, researchers are working to develop new therapies that target the underlying genetic mutations. These efforts include gene therapy, mitochondrial-targeted antioxidants, and other innovative approaches. The study of MM has also shed light on the importance of mitochondrial function in overall health and disease. Mitochondria are responsible for producing the majority of the energy that cells need to function, and their dysfunction has been implicated in a wide range of diseases, including cancer, neurodegenerative disorders, and metabolic disorders. INFOBOX: - **Name:** Mitochondrial Myopathies - **Type:** Rare genetic disorder - **Date:** 1957 (first reported case) - **Location:** Worldwide - **Known For:** Progressive muscle weakness, fatigue, and other systemic symptoms TAGS: Mitochondrial Myopathies, Kearns-Sayre Syndrome, Myoclonic Epilepsy with Ragged-Red Fibers, Chronic Progressive External Ophthalmoplegia, Mitochondrial DNA, Genetic Disorders, Rare Diseases, Muscle Weakness, Fatigue, Exercise Intolerance.
Health & MedicineConditions Encyclopedia Entry 1778737984
** This entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial Myopathies (MMs) are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which is separate from the DNA found in the cell's nucleus. MMs are characterized by muscle weakness, fatigue, and other symptoms related to impaired energy production. The disorders can affect individuals of any age, but they are more common in women due to the way mitochondria are inherited. Mitochondrial Myopathies are often classified into several subtypes, including: - **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: characterized by muscle spasms, seizures, and other neurological symptoms. - **Kearns-Sayre Syndrome (KSS)**: characterized by progressive external ophthalmoplegia, heart block, and other systemic symptoms. - **NARP Syndrome**: characterized by neuropathy, ataxia, and retinitis pigmentosa. - **MELAS Syndrome**: characterized by mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes. ## History/Background The first reported case of a mitochondrial myopathy was in 1965, when a British physician, **John Morgan Hughes**, described a patient with progressive external ophthalmoplegia. However, it wasn't until the 1980s that the genetic basis of these disorders was understood. The discovery of the mitochondrial DNA and its role in energy production led to a greater understanding of the pathophysiology of MMs. ## Key Information Mitochondrial Myopathies are caused by mutations in the mitochondrial DNA, which can be inherited from either parent. The disorders can be classified into several subtypes based on the specific mutation and the symptoms presented. Some common symptoms of MMs include: - Muscle weakness and fatigue - Muscle pain and cramping - Seizures and other neurological symptoms - Vision loss and eye problems - Heart problems and arrhythmias - Gastrointestinal problems ## Significance Mitochondrial Myopathies are significant because they highlight the importance of mitochondrial function in maintaining cellular energy production. The disorders also underscore the importance of genetic testing and counseling for individuals and families affected by these conditions. While there is currently no cure for MMs, various treatments are available to manage symptoms and slow disease progression. ## InfoBox: - **Name:** Mitochondrial Myopathies - **Type:** Rare genetic disorders - **Date:** 1965 (first reported case) - **Location:** Worldwide - **Known For:** Impaired energy production in cells ## Tags: Mitochondrial Myopathies, Rare Genetic Disorders, Mitochondrial DNA, Energy Production, Muscle Weakness, Fatigue, Seizures, Vision Loss, Heart Problems, Gastrointestinal Problems, Genetic Testing, Counseling.
Health & MedicineConditions Encyclopedia Entry 1776704705
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial Myopathies (MMs) are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which leads to impaired energy production and cellular damage. MMs can affect various parts of the body, including the muscles, nervous system, and other organs. The symptoms of MMs can vary widely depending on the specific type and severity of the disorder. There are several types of Mitochondrial Myopathies, including: * **Kearns-Sayre Syndrome (KSS)**: a rare disorder characterized by progressive external ophthalmoplegia, pigmentary retinopathy, and cardiac conduction defects. * **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: a disorder characterized by myoclonic seizures, ataxia, and ragged-red fibers on muscle biopsy. * **Neuropathy, Ataxia, and Retinitis Pigmentosa (NARP)**: a disorder characterized by neuropathy, ataxia, and retinitis pigmentosa. ## History/Background Mitochondrial Myopathies were first described in the 1960s, but it wasn't until the 1980s that the genetic basis of these disorders was understood. The discovery of mitochondrial DNA mutations as the cause of MMs revolutionized the field of genetics and led to a greater understanding of the role of mitochondria in human disease. ## Key Information * **Prevalence**: Mitochondrial Myopathies are rare disorders, affecting approximately 1 in 5,000 to 1 in 10,000 people. * **Causes**: MMs are caused by mutations in the mitochondrial DNA, which leads to impaired energy production and cellular damage. * **Symptoms**: The symptoms of MMs can vary widely depending on the specific type and severity of the disorder. Common symptoms include muscle weakness, fatigue, seizures, and vision loss. * **Diagnosis**: Diagnosis of MMs is typically made through a combination of clinical evaluation, genetic testing, and muscle biopsy. * **Treatment**: There is currently no cure for MMs, but treatment options are available to manage symptoms and slow disease progression. ## Significance Mitochondrial Myopathies are significant because they highlight the importance of mitochondria in human health and disease. The study of MMs has led to a greater understanding of the role of mitochondria in energy production and cellular function, and has shed light on the genetic basis of these disorders. Additionally, the study of MMs has led to the development of new treatments and therapies for these disorders. INFOBOX: - Name: Mitochondrial Myopathies - Type: Rare genetic disorders - Date: 1960s (first described) - Location: Global - Known For: Impaired energy production and cellular damage due to mitochondrial DNA mutations TAGS: Mitochondrial Myopathies, Kearns-Sayre Syndrome, Myoclonic Epilepsy with Ragged-Red Fibers, Neuropathy, Ataxia, and Retinitis Pigmentosa, Mitochondrial DNA, Energy Production, Cellular Damage, Rare Genetic Disorders, Genetic Testing, Muscle Biopsy.
Health & MedicineConditions Encyclopedia Entry 1775973964
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial Myopathies (MM) are a complex and diverse group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are characterized by the impaired function of the mitochondria, leading to a range of symptoms and complications. Mitochondrial myopathies can affect various parts of the body, including the muscles, nervous system, and other organs. The symptoms of MM can vary widely, depending on the specific disorder and the individual affected. Mitochondrial myopathies are typically inherited in an **autosomal dominant** or **maternal inheritance** pattern, meaning that a single copy of the mutated gene is enough to cause the disorder. This is because mitochondrial DNA is inherited solely from the mother, and mutations in the mitochondrial genome can be passed down from mother to child. The disorders are often diagnosed in childhood or adolescence, but some cases may not be diagnosed until adulthood. ## History/Background The first descriptions of mitochondrial myopathies date back to the 1960s, when researchers began to identify the role of mitochondria in energy production. However, it wasn't until the 1980s that the genetic basis of these disorders was understood. The discovery of the mitochondrial genome and the development of techniques for analyzing mitochondrial DNA led to a greater understanding of the causes and mechanisms of mitochondrial myopathies. Key milestones in the history of mitochondrial myopathies include: * 1960s: First descriptions of mitochondrial myopathies * 1980s: Discovery of the mitochondrial genome and development of techniques for analyzing mitochondrial DNA * 1990s: Identification of the genetic basis of mitochondrial myopathies * 2000s: Development of new treatments and therapies for mitochondrial myopathies ## Key Information Mitochondrial myopathies are characterized by a range of symptoms and complications, including: * Muscle weakness and wasting * Fatigue and exercise intolerance * Neurological symptoms, such as seizures and cognitive impairment * Vision and hearing loss * Cardiac problems, such as arrhythmias and heart failure * Gastrointestinal problems, such as constipation and diarrhea The diagnosis of mitochondrial myopathies typically involves a combination of clinical evaluation, genetic testing, and imaging studies. Genetic testing can identify mutations in the mitochondrial genome, while imaging studies can help to rule out other conditions that may cause similar symptoms. ## Significance Mitochondrial myopathies are a significant public health concern, affecting an estimated 1 in 5,000 to 1 in 10,000 people worldwide. These disorders can have a profound impact on the quality of life of affected individuals and their families, and can also have significant economic and social costs. The significance of mitochondrial myopathies extends beyond the individual and family level, as these disorders can also have broader implications for our understanding of human disease and our approach to healthcare. The study of mitochondrial myopathies has led to a greater understanding of the role of mitochondria in human health and disease, and has also highlighted the importance of genetic testing and personalized medicine in the diagnosis and treatment of these disorders. INFOBOX: - **Name:** Mitochondrial Myopathies - **Type:** Rare genetic disorders - **Date:** 1960s (first descriptions) - **Location:** Global - **Known For:** Impaired mitochondrial function and genetic inheritance TAGS: Mitochondrial Myopathies, Rare Genetic Disorders, Mitochondrial Dysfunction, Genetic Inheritance, Autosomal Dominant, Maternal Inheritance, Muscle Weakness, Fatigue, Neurological Symptoms, Vision and Hearing Loss.
Health & MedicineConditions Encyclopedia Entry 1780592884
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT:** ## Overview Mitochondrial Myopathies (MM) are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are characterized by the accumulation of mutations in the mitochondrial DNA, leading to impaired energy production and subsequent damage to various tissues, particularly muscles. Mitochondrial Myopathies are often inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is enough to cause the condition. The symptoms of MM can vary widely, but often include muscle weakness, fatigue, and other systemic symptoms. Mitochondrial Myopathies are a complex and heterogeneous group of disorders, with over 150 different mutations identified in the mitochondrial DNA. The most common forms of MM include Myoclonic Epilepsy with Ragged-Red Fibers (MERRF), Kearns-Sayre Syndrome (KSS), and Chronic Progressive External Ophthalmoplegia (CPEO). Each of these conditions has distinct clinical features and prognoses, but all share a common underlying pathophysiology related to mitochondrial dysfunction. ## History/Background The first reported cases of Mitochondrial Myopathies date back to the 1960s, when a group of researchers identified a unique pattern of muscle damage in patients with myoclonic epilepsy. However, it wasn't until the 1980s that the underlying genetic cause of these disorders was identified. The discovery of the mitochondrial DNA and its role in energy production paved the way for a deeper understanding of the pathophysiology of MM. Since then, numerous studies have shed light on the molecular mechanisms underlying these disorders, leading to the development of new diagnostic and therapeutic strategies. ## Key Information Mitochondrial Myopathies are characterized by a range of clinical features, including: * Muscle weakness and wasting * Fatigue and exercise intolerance * Ophthalmoplegia (weakness of the eye muscles) * Epilepsy and seizures * Hearing loss and vision impairment * Cardiac conduction defects * Endocrine abnormalities The diagnosis of MM typically involves a combination of clinical evaluation, laboratory tests, and genetic analysis. Muscle biopsy is a key diagnostic tool, as it allows for the visualization of ragged-red fibers, a hallmark of mitochondrial myopathies. Genetic testing can identify the specific mutation responsible for the condition, which can inform prognosis and treatment decisions. ## Significance Mitochondrial Myopathies are a significant public health concern, affecting an estimated 1 in 5,000 individuals worldwide. While the exact prevalence of MM is unknown, it is estimated that over 100,000 people in the United States alone are affected by these disorders. The impact of MM on individuals and families cannot be overstated, as these disorders often result in significant disability, reduced quality of life, and increased healthcare costs. ## INFOBOX: - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** 1960s (first reported cases) - **Location:** Global - **Known For:** Rare genetic disorders affecting mitochondrial energy production ## TAGS: Mitochondrial Myopathies, genetic disorders, mitochondrial DNA, muscle weakness, fatigue, epilepsy, ophthalmoplegia, hearing loss, vision impairment, cardiology, endocrinology, genetic testing, muscle biopsy, ragged-red fibers.
Health & MedicineConditions Encyclopedia Entry 1778906644
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT:** ## Overview Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which is separate from the DNA found in the cell's nucleus. Mitochondrial myopathies can affect various parts of the body, including the muscles, brain, and other organs. The symptoms of mitochondrial myopathies can vary widely, but often include muscle weakness, fatigue, and other neurological problems. Mitochondrial myopathies are often inherited in an **autosomal dominant** or **maternal inheritance** pattern, meaning that a single copy of the mutated gene is enough to cause the condition. In some cases, the condition can be caused by a new mutation, rather than an inherited one. The exact prevalence of mitochondrial myopathies is unknown, but it is estimated to affect about 1 in 5,000 to 1 in 10,000 people. ## History/Background The first cases of mitochondrial myopathies were described in the 1960s, but it wasn't until the 1980s that the genetic basis of these disorders was understood. In 1988, a team of scientists led by Dr. Doug Wallace discovered that mitochondrial myopathies were caused by mutations in the mitochondrial DNA. This discovery revolutionized the field of genetics and paved the way for the development of genetic testing for these disorders. ## Key Information There are several types of mitochondrial myopathies, including: * **Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)**: a condition characterized by muscle weakness, seizures, and episodes of lactic acidosis. * **Myoclonic epilepsy with ragged-red fibers (MERRF)**: a condition characterized by muscle weakness, seizures, and ragged-red fibers in muscle tissue. * **Kearns-Sayre syndrome (KSS)**: a condition characterized by muscle weakness, heart problems, and vision loss. * **Leigh syndrome**: a condition characterized by muscle weakness, seizures, and brain damage. The symptoms of mitochondrial myopathies can vary widely, but often include: * Muscle weakness and fatigue * Neurological problems, such as seizures and vision loss * Cardiac problems, such as heart failure * Gastrointestinal problems, such as diarrhea and abdominal pain * Endocrine problems, such as diabetes and thyroid problems ## Significance Mitochondrial myopathies are a significant cause of morbidity and mortality in affected individuals. The symptoms of these disorders can be severe and debilitating, and there is currently no cure. However, with proper management and treatment, individuals with mitochondrial myopathies can lead active and fulfilling lives. ## INFOBOX: - **Name:** Mitochondrial Myopathies - **Type:** Genetic Disorders - **Date:** 1960s (first cases described) - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting the mitochondria ## TAGS: Genetic Disorders, Mitochondrial Myopathies, MELAS, MERRF, KSS, Leigh Syndrome, Muscle Weakness, Neurological Problems
Health & MedicineConditions Encyclopedia Entry 1782342966
Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within muscle cells, leading to muscle weakness, fatigue, and other systemic symptoms. ## Overview Mitochondrial myopathies are a diverse group of disorders caused by mutations in the mitochondrial DNA (mtDNA) or nuclear DNA (nDNA) that affect the function of the mitochondria. Mitochondria are the powerhouses of cells, responsible for generating energy in the form of ATP (adenosine triphosphate). In individuals with mitochondrial myopathies, the mitochondria are unable to produce sufficient energy, leading to muscle weakness, fatigue, and other systemic symptoms. These disorders can affect any muscle group, but the muscles of the face, eyes, and limbs are commonly affected. Mitochondrial myopathies are often inherited in an autosomal dominant or maternal pattern, meaning that a single copy of the mutated gene is sufficient to cause the disorder. The symptoms of mitochondrial myopathies can vary widely, even within the same family. Some individuals may experience mild symptoms, while others may experience more severe symptoms that significantly impact their quality of life. ## History/Background The first cases of mitochondrial myopathies were described in the 1960s, but it wasn't until the 1980s that the genetic basis of these disorders was understood. The discovery of the mitochondrial DNA and its role in energy production revolutionized our understanding of these disorders. Since then, numerous studies have identified the genetic mutations responsible for mitochondrial myopathies and developed diagnostic tests to detect these mutations. ## Key Information Mitochondrial myopathies are classified into several subtypes, including: * **Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)**: a subtype characterized by seizures, muscle weakness, and lactic acidosis. * **Myoclonic epilepsy with ragged-red fibers (MERRF)**: a subtype characterized by seizures, muscle weakness, and ragged-red fibers (abnormal muscle fibers) on muscle biopsy. * **Kearns-Sayre syndrome (KSS)**: a subtype characterized by progressive external ophthalmoplegia (weakness of the eye muscles), heart block, and pigmentary retinopathy. * **Leigh syndrome**: a subtype characterized by progressive brain damage, muscle weakness, and lactic acidosis. ## Significance Mitochondrial myopathies are significant because they highlight the importance of mitochondrial function in maintaining muscle and overall health. These disorders also underscore the importance of genetic testing and counseling for individuals and families affected by these disorders. Early diagnosis and treatment can significantly improve the quality of life for individuals with mitochondrial myopathies. INFOBOX: - Name: Mitochondrial Myopathies - Type: Genetic Disorders - Date: 1960s (first cases described) - Location: Global (affecting individuals worldwide) - Known For: Rare genetic disorders affecting mitochondrial function TAGS: Mitochondrial Myopathies, Genetic Disorders, Muscle Weakness, Fatigue, Lactic Acidosis, MELAS, MERRF, KSS, Leigh Syndrome, Mitochondrial DNA, Nuclear DNA.
Health & MedicineConditions Encyclopedia Entry 1781724608
** This article provides an in-depth overview of **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial Myopathies (MM) are a collection of rare genetic disorders characterized by the impaired functioning of the mitochondria, the energy-producing structures within cells. These disorders can affect various parts of the body, including the muscles, brain, and other organs. Mitochondrial Myopathies are caused by mutations in the mitochondrial DNA, which can lead to a range of symptoms, including muscle weakness, fatigue, and neurological problems. The disorders are often inherited in an autosomal dominant or maternal pattern, meaning that a single copy of the mutated gene is enough to cause the condition, and mothers can pass the condition to their children. Mitochondrial Myopathies are relatively rare, affecting approximately 1 in 5,000 to 1 in 10,000 people worldwide. However, the exact prevalence of the disorders is difficult to determine due to the lack of a centralized registry and the variability in symptoms and severity. Despite their rarity, Mitochondrial Myopathies can have a significant impact on the quality of life of those affected, with many individuals experiencing progressive muscle weakness, fatigue, and other debilitating symptoms. ## History/Background The first reported cases of Mitochondrial Myopathies date back to the 1960s, when researchers identified a group of patients with muscle weakness and other symptoms that were not responsive to conventional treatments. In the 1980s, the discovery of mitochondrial DNA mutations led to a greater understanding of the underlying causes of the disorders. Since then, numerous studies have shed light on the genetic and molecular mechanisms underlying Mitochondrial Myopathies, leading to the development of new diagnostic tools and treatments. ## Key Information Mitochondrial Myopathies are caused by mutations in the mitochondrial DNA, which can lead to impaired energy production within cells. The disorders can be classified into several subtypes, including: * **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: characterized by muscle weakness, seizures, and other neurological symptoms. * **Kearns-Sayre Syndrome (KSS)**: characterized by muscle weakness, heart problems, and other systemic symptoms. * **Leigh Syndrome**: characterized by muscle weakness, seizures, and other neurological symptoms. * **NARP Syndrome**: characterized by muscle weakness, seizures, and other neurological symptoms. Symptoms of Mitochondrial Myopathies can vary widely, depending on the subtype and severity of the disorder. Common symptoms include: * Muscle weakness and fatigue * Muscle pain and cramping * Seizures and other neurological symptoms * Vision loss and other eye problems * Hearing loss and other auditory problems * Heart problems and other systemic symptoms ## Significance Mitochondrial Myopathies are significant because they highlight the importance of mitochondrial function in maintaining overall health. The disorders also underscore the need for early diagnosis and treatment, as well as the importance of genetic counseling for families affected by the conditions. INFOBOX: - **Name:** Mitochondrial Myopathies - **Type:** Rare genetic disorders - **Date:** 1960s (first reported cases) - **Location:** Worldwide - **Known For:** Impaired mitochondrial function leading to muscle weakness, fatigue, and other debilitating symptoms TAGS: Mitochondrial Myopathies, rare genetic disorders, mitochondrial DNA mutations, muscle weakness, fatigue, neurological symptoms, genetic counseling, early diagnosis, treatment.
Health & MedicineConditions Encyclopedia Entry 1778688320
** This entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which is separate from the DNA found in the cell's nucleus. Mitochondrial myopathies can affect various parts of the body, including the muscles, nervous system, and other organs. The symptoms of these disorders can vary widely, but often include muscle weakness, fatigue, and other systemic problems. Mitochondrial myopathies are often inherited in an **autosomal** pattern, meaning that a person can inherit the mutated gene from either parent. However, some cases can also occur spontaneously due to new mutations. The disorders can affect people of all ages, but they are more common in women due to the way in which mitochondrial DNA is inherited. ## History/Background The first descriptions of mitochondrial myopathies date back to the 1960s, when researchers began to identify the role of mitochondria in energy production. In the 1980s, scientists discovered the first mitochondrial DNA mutations associated with these disorders. Since then, numerous studies have identified many different mutations that can cause mitochondrial myopathies. ## Key Information There are several types of mitochondrial myopathies, including: - **Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS)**: This is one of the most common forms of mitochondrial myopathy, characterized by episodes of stroke-like symptoms, lactic acidosis, and other systemic problems. - **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: This disorder is characterized by muscle weakness, seizures, and other systemic problems. - **Kearns-Sayre Syndrome (KSS)**: This disorder is characterized by progressive external ophthalmoplegia, heart block, and other systemic problems. ## Significance Mitochondrial myopathies are significant because they can have a major impact on a person's quality of life. The disorders can cause significant muscle weakness, fatigue, and other systemic problems, which can affect a person's ability to perform daily activities. In some cases, the disorders can also be life-threatening. Research into mitochondrial myopathies has led to a greater understanding of the role of mitochondria in energy production and the importance of mitochondrial DNA in maintaining cellular function. This research has also led to the development of new treatments and therapies for these disorders. INFOBOX: - Name: Mitochondrial Myopathies - Type: Genetic Disorders - Date: 1960s (first descriptions) - Location: Worldwide - Known For: Rare genetic disorders affecting the mitochondria TAGS: Mitochondrial Myopathies, Genetic Disorders, Mitochondrial DNA, Energy Production, Muscle Weakness, Fatigue, Systemic Problems, Autosomal Inheritance, MELAS, MERRF, KSS.
Health & MedicineConditions Encyclopedia Entry 1780689126
** This article discusses **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial Myopathies (MM) are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are characterized by progressive muscle weakness, wasting, and other systemic symptoms. MM are caused by mutations in the mitochondrial DNA, which is inherited from one's mother. The symptoms of MM can vary widely, depending on the specific mutation and the affected individual. Common symptoms include muscle weakness, fatigue, and pain, as well as vision and hearing loss, and developmental delays. Mitochondrial Myopathies are often classified into several subtypes, including: * **Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS)**: a severe subtype characterized by recurrent episodes of stroke-like symptoms, lactic acidosis, and other systemic symptoms. * **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: a subtype characterized by myoclonic seizures, muscle weakness, and other systemic symptoms. * **Kearns-Sayre Syndrome (KSS)**: a subtype characterized by progressive external ophthalmoplegia, heart block, and other systemic symptoms. ## History/Background The first reported case of Mitochondrial Myopathies dates back to 1963, when a British neurologist, **William Kearns**, described a patient with progressive external ophthalmoplegia and other systemic symptoms. However, it wasn't until the 1980s that the genetic basis of MM was identified, with the discovery of mutations in the mitochondrial DNA. Since then, numerous studies have been conducted to better understand the pathophysiology and clinical manifestations of MM. ## Key Information * **Inheritance**: Mitochondrial Myopathies are inherited in a maternal lineage, meaning that the mutated mitochondrial DNA is passed from mother to child. * **Prevalence**: MM are rare disorders, affecting approximately 1 in 5,000 to 1 in 10,000 individuals. * **Symptoms**: Common symptoms include muscle weakness, fatigue, pain, vision and hearing loss, and developmental delays. * **Diagnosis**: Diagnosis is typically made through a combination of clinical evaluation, genetic testing, and muscle biopsy. * **Treatment**: There is no cure for MM, but various treatments are available to manage symptoms and slow disease progression. ## Significance Mitochondrial Myopathies are significant because they highlight the importance of mitochondrial function in maintaining cellular energy production. Understanding the pathophysiology of MM has led to the development of new treatments for other mitochondrial disorders, such as **Leigh Syndrome** and **NARP Syndrome**. Additionally, research on MM has shed light on the role of mitochondrial DNA in human disease, which has implications for our understanding of aging and age-related diseases. INFOBOX: - **Name:** Mitochondrial Myopathies - **Type:** Rare genetic disorders - **Date:** 1963 (first reported case) - **Location:** Worldwide - **Known For:** Progressive muscle weakness, wasting, and other systemic symptoms TAGS: Mitochondrial Myopathies, rare genetic disorders, mitochondrial DNA, muscle weakness, fatigue, pain, vision and hearing loss, developmental delays, MELAS, MERRF, KSS, Kearns-Sayre Syndrome.
Health & MedicineConditions Encyclopedia Entry 1777250705
Mitochondrial myopathies are a group of rare genetic disorders characterized by the impaired function of mitochondria, the energy-producing structures within muscle cells, leading to muscle weakness, fatigue, and other systemic symptoms. ## Overview Mitochondrial myopathies are a diverse group of disorders caused by mutations in mitochondrial DNA (mtDNA) or nuclear DNA (nDNA) that affect the function of mitochondria. These organelles are responsible for generating energy in the form of ATP (adenosine triphosphate) through the process of cellular respiration. In individuals with mitochondrial myopathies, the impaired function of mitochondria leads to a buildup of toxic byproducts, oxidative stress, and ultimately, muscle damage and weakness. The symptoms of mitochondrial myopathies can vary widely depending on the specific mutation and the affected tissues, but common features include muscle weakness, fatigue, exercise intolerance, and other systemic symptoms such as gastrointestinal problems, cardiac issues, and neurological disorders. Mitochondrial myopathies are often inherited in an autosomal dominant or recessive pattern, meaning that a single copy of the mutated gene is sufficient to cause the disorder. However, some cases may be sporadic, resulting from de novo mutations. The diagnosis of mitochondrial myopathies typically involves a combination of clinical evaluation, laboratory tests, and genetic analysis. Treatment options are limited, and management focuses on symptom relief, lifestyle modifications, and supportive care. ## History/Background The first reported cases of mitochondrial myopathies date back to the 1960s, when researchers identified a group of patients with muscle weakness and fatigue who had abnormal muscle biopsies. Over the years, advances in molecular genetics and biochemical analysis have led to a better understanding of the underlying causes of these disorders. In 1988, the first mitochondrial DNA mutation was identified in a patient with mitochondrial myopathy, marking a significant milestone in the field. Since then, numerous studies have shed light on the genetic and biochemical mechanisms underlying these disorders. ## Key Information Mitochondrial myopathies are classified into several subtypes, including: * **Kearns-Sayre syndrome**: a rare disorder caused by a deletion in mtDNA, characterized by muscle weakness, eye abnormalities, and cardiac conduction defects. * **Myoclonic epilepsy with ragged-red fibers (MERRF)**: a disorder caused by a point mutation in mtDNA, characterized by muscle weakness, seizures, and ragged-red fibers in muscle biopsies. * **Neuropathy, ataxia, and retinitis pigmentosa (NARP)**: a disorder caused by a point mutation in mtDNA, characterized by muscle weakness, ataxia, and visual impairment. * **Leigh syndrome**: a disorder caused by a point mutation in mtDNA, characterized by muscle weakness, seizures, and developmental delay. ## Significance Mitochondrial myopathies are relatively rare, affecting approximately 1 in 5,000 to 1 in 10,000 individuals. However, these disorders have significant implications for affected individuals and their families. The impaired function of mitochondria can lead to a range of systemic symptoms, including muscle weakness, fatigue, and other debilitating conditions. Moreover, the genetic nature of these disorders means that they can be passed down to future generations, highlighting the importance of genetic counseling and testing. INFOBOX: - Name: Mitochondrial Myopathies - Type: Genetic Disorders - Date: 1960s (first reported cases) - Location: Worldwide - Known For: Impaired function of mitochondria leading to muscle weakness and systemic symptoms TAGS: Mitochondrial Myopathies, Genetic Disorders, Muscle Weakness, Fatigue, Exercise Intolerance, Gastrointestinal Problems, Cardiac Issues, Neurological Disorders, Genetic Counseling, Mitochondrial DNA, Nuclear DNA.
Health & MedicineConditions Encyclopedia Entry 1776405250
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial Myopathies (MM) are a group of rare genetic disorders caused by mutations in the mitochondrial DNA. These conditions affect the mitochondria, which are responsible for generating energy for the cell through a process called cellular respiration. Mitochondrial myopathies can affect various parts of the body, including the muscles, nervous system, and other organs. The symptoms of MM can vary widely, depending on the specific condition and the individual affected. Mitochondrial myopathies are often inherited in an **autosomal dominant** or **maternal inheritance** pattern, meaning that a single copy of the mutated gene is sufficient to cause the condition. The conditions are typically diagnosed through a combination of clinical evaluation, laboratory tests, and genetic analysis. There is currently no cure for mitochondrial myopathies, but various treatments and therapies can help manage the symptoms and slow disease progression. ## History/Background Mitochondrial myopathies were first described in the 1960s, but it wasn't until the 1980s that the genetic basis of these conditions was understood. In 1988, the first mitochondrial DNA mutation was identified as the cause of a mitochondrial myopathy. Since then, numerous other mutations have been identified, and the conditions have been classified into several distinct subtypes. ## Key Information **Types of Mitochondrial Myopathies:** 1. **Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS)**: A condition characterized by episodes of stroke-like symptoms, lactic acidosis, and muscle weakness. 2. **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: A condition characterized by muscle stiffness, seizures, and ragged-red fibers in muscle tissue. 3. **Kearns-Sayre Syndrome (KSS)**: A condition characterized by progressive external ophthalmoplegia, heart block, and other systemic symptoms. 4. **Leigh Syndrome**: A condition characterized by progressive brain damage, muscle weakness, and other systemic symptoms. **Symptoms:** * Muscle weakness and wasting * Fatigue and exercise intolerance * Seizures and epilepsy * Vision loss and hearing loss * Cognitive impairment and dementia * Cardiac arrhythmias and heart failure ## Significance Mitochondrial myopathies are rare conditions that affect approximately 1 in 5,000 to 1 in 10,000 people worldwide. While the conditions are rare, they can have a significant impact on the quality of life of affected individuals and their families. Early diagnosis and management are essential to slow disease progression and improve outcomes. **Research and Treatment:** Research into mitochondrial myopathies is ongoing, with a focus on understanding the genetic and molecular mechanisms underlying these conditions. Various treatments and therapies are available to manage the symptoms and slow disease progression, including: * **Coenzyme Q10 (CoQ10)**: A supplement that helps generate energy for the cell. * **Thiamine**: A vitamin that helps regulate energy metabolism. * **Physical therapy**: To improve muscle strength and mobility. * **Speech and language therapy**: To improve communication skills. * **Cognitive therapy**: To improve cognitive function. INFOBOX: - **Name:** Mitochondrial Myopathies - **Type:** Rare genetic disorders - **Date:** 1960s (first described), 1988 (genetic basis understood) - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting the mitochondria TAGS: Mitochondrial Myopathies, Rare Genetic Disorders, Mitochondrial DNA, Autosomal Dominant, Maternal Inheritance, Coenzyme Q10, Thiamine, Physical Therapy, Speech and Language Therapy, Cognitive Therapy.
Health & MedicineConditions Encyclopedia Entry 1780224665
** This entry refers to **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial Myopathies (MM) are a diverse group of rare genetic disorders characterized by the impaired function of the mitochondria, the energy-producing structures within cells. These disorders affect various tissues and organs, particularly those with high energy demands, such as the muscles, brain, and heart. Mitochondrial Myopathies are caused by mutations in the mitochondrial DNA (mtDNA) or nuclear DNA (nDNA) that disrupt the normal functioning of the mitochondria, leading to a range of symptoms and complications. Mitochondrial Myopathies are often inherited in an autosomal dominant or maternal pattern, meaning that a single copy of the mutated gene is sufficient to cause the disorder. The symptoms of MM can vary widely depending on the specific mutation and the affected individual, but common features include muscle weakness, fatigue, exercise intolerance, and neurological problems. In some cases, MM can also lead to more severe complications, such as heart failure, seizures, and vision loss. ## History/Background The first descriptions of Mitochondrial Myopathies date back to the early 20th century, when researchers began to recognize the importance of mitochondria in cellular energy production. However, it wasn't until the 1960s and 1970s that the genetic basis of these disorders began to be understood. The discovery of mitochondrial DNA (mtDNA) in 1964 marked a significant turning point in the study of Mitochondrial Myopathies, as it allowed researchers to identify specific mutations associated with these disorders. In the 1980s and 1990s, advances in genetic testing and molecular biology enabled the development of diagnostic tests for Mitochondrial Myopathies. Today, these tests can identify specific mutations in the mtDNA or nDNA that are associated with these disorders. Despite the progress made in understanding and diagnosing Mitochondrial Myopathies, there is still much to be learned about these complex disorders. ## Key Information Mitochondrial Myopathies are caused by mutations in the mitochondrial DNA (mtDNA) or nuclear DNA (nDNA) that disrupt the normal functioning of the mitochondria. The most common mutations associated with MM include: * **MELAS syndrome**: A disorder characterized by muscle weakness, seizures, and lactic acidosis. * **MERRF syndrome**: A disorder characterized by muscle weakness, myoclonus, and ataxia. * **KSS syndrome**: A disorder characterized by muscle weakness, ataxia, and pigmentary retinopathy. Other key features of Mitochondrial Myopathies include: * **Muscle weakness**: A common symptom of MM, particularly in the muscles of the face, arms, and legs. * **Fatigue**: A persistent feeling of tiredness or exhaustion that can be debilitating. * **Exercise intolerance**: A reduced ability to engage in physical activity due to muscle weakness or fatigue. * **Neurological problems**: A range of symptoms, including seizures, ataxia, and vision loss. ## Significance Mitochondrial Myopathies are a significant public health concern due to their rarity and complexity. These disorders can have a profound impact on the quality of life of affected individuals and their families. Despite the challenges associated with MM, researchers and clinicians are working to develop new treatments and therapies that can improve the lives of those affected by these disorders. In addition to their clinical significance, Mitochondrial Myopathies have also contributed to our understanding of the importance of mitochondria in cellular energy production. The study of these disorders has led to a greater appreciation of the complex interactions between mitochondria, nuclear DNA, and other cellular components. INFOBOX: - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** First described in the early 20th century - **Location:** Global - **Known For:** Rare genetic disorders affecting the mitochondria, leading to muscle weakness, fatigue, and neurological problems. TAGS: Mitochondrial Myopathies, genetic disorders, mitochondrial DNA, nuclear DNA, muscle weakness, fatigue, exercise intolerance, neurological problems, MELAS syndrome, MERRF syndrome, KSS syndrome.
Health & MedicineConditions Encyclopedia Entry 1782265948
Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells, leading to muscle weakness and other systemic symptoms.
Health & MedicineConditions Encyclopedia Entry 1777737965
Mitochondrial myopathies are a group of rare genetic disorders characterized by muscle weakness and degeneration due to impaired mitochondrial function.
Health & MedicineConditions Encyclopedia Entry 1780472525
** This entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial Myopathies (MM) are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which is separate from the DNA found in the cell's nucleus. As a result, the mitochondria are unable to produce energy efficiently, leading to a range of symptoms and complications. Mitochondrial Myopathies can affect anyone, but they are more common in women, as they can pass the mutated mitochondrial DNA to their offspring. Mitochondrial Myopathies are characterized by a range of symptoms, including muscle weakness, fatigue, and exercise intolerance. Some people may experience muscle pain, cramping, or spasms, while others may experience vision problems, hearing loss, or cognitive impairment. In severe cases, Mitochondrial Myopathies can lead to life-threatening complications, such as heart failure or respiratory failure. ## History/Background The first reported case of Mitochondrial Myopathy was in 1962, when a British doctor, Brian Shyng, described a patient with a rare disorder that affected the muscles. However, it wasn't until the 1980s that the genetic basis of Mitochondrial Myopathies was discovered. In 1988, a team of scientists led by Douglas Wallace identified the first mitochondrial DNA mutation associated with a Mitochondrial Myopathy. Since then, numerous other mutations have been identified, and the condition has been recognized as a distinct group of disorders. ## Key Information Mitochondrial Myopathies are caused by mutations in the mitochondrial DNA, which are inherited from one's mother. There are over 200 known mitochondrial DNA mutations associated with Mitochondrial Myopathies, each with its own unique set of symptoms and characteristics. Some of the most common mutations include: - **MELAS** (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes): a severe form of Mitochondrial Myopathy that affects the brain, muscles, and other organs. - **MERRF** (Myoclonus Epilepsy with Ragged-Red Fibers): a form of Mitochondrial Myopathy that affects the muscles, brain, and other organs. - **KSS** (Kearns-Sayre Syndrome): a rare form of Mitochondrial Myopathy that affects the muscles, heart, and other organs. ## Significance Mitochondrial Myopathies are a significant public health concern, as they can affect anyone, regardless of age or background. While they are rare, they can have a profound impact on the lives of those affected, as well as their families. Research into Mitochondrial Myopathies has led to a greater understanding of the role of mitochondria in human health and disease, and has paved the way for the development of new treatments and therapies. INFOBOX: - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** 1962 (first reported case) - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting the mitochondria TAGS: Mitochondrial Myopathies, genetic disorders, mitochondrial DNA, energy production, muscle weakness, fatigue, exercise intolerance, rare diseases.